| __timestamp | Takeda Pharmaceutical Company Limited | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 382096000000 | 15411924 |
| Thursday, January 1, 2015 | 345927000000 | 22593274 |
| Friday, January 1, 2016 | 312303000000 | 33173050 |
| Sunday, January 1, 2017 | 325441000000 | 62224159 |
| Monday, January 1, 2018 | 368298000000 | 95607434 |
| Tuesday, January 1, 2019 | 492381000000 | 221269028 |
| Wednesday, January 1, 2020 | 455833000000 | 400745069 |
| Friday, January 1, 2021 | 526087000000 | 580520000 |
| Saturday, January 1, 2022 | 633325000000 | 663366000 |
| Sunday, January 1, 2023 | 729924000000 | 755113687 |
| Monday, January 1, 2024 | 729924000000 |
Unlocking the unknown
In the ever-evolving world of pharmaceuticals, innovation is key to staying ahead. Takeda Pharmaceutical Company Limited and argenx SE are two companies that have shown a commitment to research and development (R&D) over the past decade. From 2014 to 2023, Takeda's R&D spending has seen a remarkable increase of approximately 91%, highlighting its dedication to innovation. In contrast, argenx SE, while starting from a smaller base, has increased its R&D expenses by an impressive 4,800% over the same period, reflecting its rapid growth and ambition.
Takeda's consistent investment, peaking in 2023, underscores its strategy to maintain a competitive edge in the global market. Meanwhile, argenx SE's exponential growth in R&D spending signals its aggressive push to establish itself as a major player. This comparison not only showcases the different scales of investment but also the diverse strategies employed by these companies in their pursuit of innovation.
Research and Development Expenses Breakdown: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Research and Development: Comparing Key Metrics for Sanofi and Takeda Pharmaceutical Company Limited
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or argenx SE
Operational Costs Compared: SG&A Analysis of Takeda Pharmaceutical Company Limited and argenx SE
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs BioMarin Pharmaceutical Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Xencor, Inc.
R&D Insights: How argenx SE and United Therapeutics Corporation Allocate Funds
Research and Development: Comparing Key Metrics for argenx SE and Insmed Incorporated
Research and Development Investment: argenx SE vs Blueprint Medicines Corporation
Research and Development Expenses Breakdown: argenx SE vs Grifols, S.A.